Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Simmons First National
SFNC
$3.45B
| $4.34M | ﹤0.01% |
253,686
+65,700
| +35% | +$1.13M |
|
1227
Tower Semiconductor
TSEM
$28.6B
| $4.34M | ﹤0.01% |
227,834
+31,409
| +16% | +$601K |
|
1228
Bankunited
BKU
$3.38B
| $4.3M | ﹤0.01% |
212,400
+28,300
| +15% | +$531K |
|
1229
J&J Snack Foods
JJSF
$1.67B
| $4.3M | ﹤0.01% |
33,800
+4,500
| +15% | +$565K |
|
1230
Telephone and Data Systems
TDS
$4.03B
| $4.29M | ﹤0.01% |
216,000
+18,000
| +9% | +$344K |
|
|
BDN
1231
Brandywine Realty Trust
BDN
$541M
| $4.29M | ﹤0.01% |
393,900
+52,200
| +15% | +$537K |
|
1232
Visteon
VC
$2.84B
| $4.29M | ﹤0.01% |
62,600
+8,400
| +15% | +$528K |
|
|
MDLA
1233
DELISTED
Medallia, Inc.
MDLA
| $4.28M | ﹤0.01% |
169,700
+119,900
| +241% | +$2.86M |
|
1234
GATX Corp
GATX
$6.34B
| $4.28M | ﹤0.01% |
70,100
+5,200
| +8% | +$313K |
|
|
MDC
1235
DELISTED
M.D.C. Holdings, Inc.
MDC
| $4.27M | ﹤0.01% |
129,231
+24,300
| +23% | +$672K |
|
1236
Denali Therapeutics
DNLI
$4.04B
| $4.27M | ﹤0.01% |
176,500
+55,400
| +46% | +$1.3M |
|
1237
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $4.27M | ﹤0.01% |
149,934
+22,500
| +18% | +$615K |
|
|
B
1238
DELISTED
Barnes Group Inc.
B
| $4.26M | ﹤0.01% |
107,800
+14,400
| +15% | +$553K |
|
1239
Innospec
IOSP
$2.31B
| $4.23M | ﹤0.01% |
54,803
+7,300
| +15% | +$534K |
|
1240
LGI Homes
LGIH
$1.32B
| $4.23M | ﹤0.01% |
48,081
+10,200
| +27% | +$715K |
|
1241
Spectrum Brands
SPB
$2.03B
| $4.23M | ﹤0.01% |
92,199
+7,100
| +8% | +$301K |
|
|
PDCO
1242
DELISTED
Patterson Companies, Inc.
PDCO
| $4.23M | ﹤0.01% |
192,300
+25,500
| +15% | +$447K |
|
1243
Inspire Medical Systems
INSP
$1.68B
| $4.22M | ﹤0.01% |
48,500
+25,200
| +108% | +$1.94M |
|
1244
Prestige Consumer Healthcare
PBH
$2.43B
| $4.21M | ﹤0.01% |
112,200
+14,800
| +15% | +$592K |
|
1245
NETSCOUT
NTCT
$2.87B
| $4.21M | ﹤0.01% |
164,828
+19,500
| +13% | +$504K |
|
|
PS
1246
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $4.2M | ﹤0.01% |
232,900
+84,800
| +57% | +$1.44M |
|
1247
Kratos Defense & Security Solutions
KTOS
$11.8B
| $4.19M | ﹤0.01% |
267,900
+92,700
| +53% | +$1.48M |
|
|
CHX
1248
DELISTED
ChampionX
CHX
| $4.19M | ﹤0.01% |
428,922
+278,722
| +186% | +$2.55M |
|
1249
IAMGOLD
IAG
$10.3B
| $4.15M | ﹤0.01% |
1,052,800
+142,100
| +16% | +$489K |
|
1250
Dorman Products
DORM
$3.97B
| $4.14M | ﹤0.01% |
61,800
+7,800
| +14% | +$502K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.